{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:31:54Z","timestamp":1788582714606,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670542"],"award-info":[{"award-number":["81670542"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2021Y0001"],"award-info":[{"award-number":["2021Y0001"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2021J011351"],"award-info":[{"award-number":["2021J011351"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Liver fibrosis is caused by a variety of chronic liver injuries and has caused significant morbidity and mortality in the world with increasing tendency. Elucidation of the molecular mechanism of liver fibrosis is the basis for intervention of this pathological process and drug development. Nucleophosmin (NPM) is a widely expressed nucleolar phosphorylated protein, which is particularly important for cell proliferation, differentiation and survival. The biological role of NPM in liver fibrosis remains unknown. Here we show that NPM promotes liver fibrosis through multiple pathways. Our study found that NPM was up-regulated in cirrhosis tissues and activated in hepatic stellate cells (HSCs). NPM inhibition reduced liver fibrosis markers expression in HSCs and inhibited the HSCs proliferation and migration. In mice model, NPM knockdown in HSCs or application of specific NPM inhibitor can remarkably attenuate hepatic fibrosis. Mechanistic analysis showed that NPM promotes hepatic fibrosis by inhibiting HSCs apoptosis through Akt\/ROS pathway and by upregulating TGF-\u03b22 through Akt-induced lncMIAT. LncMIAT up-regulated TGF-\u03b22 mRNA by competitively sponging miR-16-5p. In response to liver injury, hepatocytes, Kupffer cells and HSCs up-regulated NPM to increase TGF-\u03b22 secretion to activate HSCs in a paracrine or autocrine manner, leading to increased liver fibrosis. Our study demonstrated that NPM regulated hepatotoxin-induced fibrosis through Akt\/ROS-induced apoptosis of HSCs and via the Akt\/lncMIAT-up-regulated TGF-\u03b22. Inhibition of NPM or application of NPM inhibitor CIGB300 remarkably attenuated liver fibrosis. NPM serves a potential new drug target for liver fibrosis.<\/jats:p>","DOI":"10.1038\/s41419-023-06043-0","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T04:01:38Z","timestamp":1693368098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["NPM promotes hepatotoxin-induced fibrosis by inhibiting ROS-induced apoptosis of hepatic stellate cells and upregulating lncMIAT-induced TGF-\u03b22"],"prefix":"10.1038","volume":"14","author":[{"given":"Xue","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Le","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Gui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Can","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1213-0550","authenticated-orcid":false,"given":"Song-Lin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,30]]},"reference":[{"key":"6043_CR1","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","volume":"60","author":"FS Wang","year":"2014","unstructured":"Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology. 2014;60:2099\u2013108.","journal-title":"Hepatology."},{"key":"6043_CR2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","volume":"61","author":"E Seki","year":"2015","unstructured":"Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 2015;61:1066\u201379.","journal-title":"Hepatology."},{"key":"6043_CR3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jgm.242","volume":"4","author":"R Safadi","year":"2002","unstructured":"Safadi R, Friedman SL. Hepatic fibrosis-role of hepatic stellate cell activation. Medscape Gen Med. 2002;4:27.","journal-title":"Medscape Gen Med"},{"key":"6043_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bbalip.2008.11.001","volume":"1791","author":"WS Blaner","year":"2009","unstructured":"Blaner WS, O\u2019Byrne SM, Wongsiriroj N, Kluwe J, D\u2019Ambrosio DM, Jiang H, et al. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim Biophys Acta. 2009;1791:467\u201373.","journal-title":"Biochim Biophys Acta"},{"key":"6043_CR5","doi-asserted-by":"publisher","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","volume":"20","author":"H Cichoz-Lach","year":"2014","unstructured":"Cichoz-Lach H, Michalak A. Oxidative stress as a crucial factor in liver diseases. World J Gastroenterol. 2014;20:8082\u201391.","journal-title":"World J Gastroenterol"},{"key":"6043_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1042\/CS20060242","volume":"112","author":"NC Henderson","year":"2007","unstructured":"Henderson NC, Iredale JP. Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci. 2007;112:265\u201380.","journal-title":"Clin Sci"},{"key":"6043_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125\u201372.","journal-title":"Physiol Rev"},{"key":"6043_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","volume":"10","author":"AM Gressner","year":"2006","unstructured":"Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76\u201399.","journal-title":"J Cell Mol Med"},{"key":"6043_CR9","doi-asserted-by":"crossref","first-page":"C6","DOI":"10.1002\/lt.20604","volume":"11","author":"S Lam","year":"2005","unstructured":"Lam S, Man K, Ng KTP, Fan ST, Lo CM. The significance of hepatic stellate cellactivation in small-for-size fatty liver graft injury. Liver Transpl. 2005;11:C6\u2013C.","journal-title":"Liver Transpl"},{"key":"6043_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol-Mech. 2011;6:425\u201356.","journal-title":"Annu Rev Pathol-Mech"},{"key":"6043_CR11","first-page":"4479","volume":"9","author":"S Herbertz","year":"2015","unstructured":"Herbertz S, Sawyer JS, Stauber AJ, Gueorguieva I, Driscoll KE, Estrem ST, et al. Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway. Drug Des Dev Ther. 2015;9:4479\u201399.","journal-title":"Drug Des Dev Ther"},{"key":"6043_CR12","first-page":"112","volume":"15","author":"C Kirmaz","year":"2004","unstructured":"Kirmaz C, Terzioglu E, Topalak O, Bayrak P, Yilmaz O, Ersoz G, et al. Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected]. Eur Cytokine Netw. 2004;15:112\u20136.","journal-title":"Eur Cytokine Netw"},{"key":"6043_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1172\/JCI118055","volume":"96","author":"DM Bissell","year":"1995","unstructured":"Bissell DM, Wang SS, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth-factor-beta in rat-liver\u2014evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest. 1995;96:447\u201355.","journal-title":"J Clin Invest"},{"key":"6043_CR14","doi-asserted-by":"publisher","first-page":"19499","DOI":"10.18632\/oncotarget.6967","volume":"7","author":"A Dropmann","year":"2016","unstructured":"Dropmann A, Dediulia T, Breitkopf-Heinlein K, Korhonen H, Janicot M, Weber SN, et al. TGF-beta1 and TGF-beta2 abundance in liver diseases of mice and men. Oncotarget. 2016;7:19499\u2013518.","journal-title":"Oncotarget."},{"key":"6043_CR15","doi-asserted-by":"publisher","first-page":"eabe0407","DOI":"10.1126\/scitranslmed.abe0407","volume":"13","author":"TH Sun","year":"2021","unstructured":"Sun TH, Huang ZY, Liang WC, Yin JP, Lin WY, Wu J, et al. TGF beta 2 and TGF beta 3 isoforms drive fibrotic disease pathogenesis. Sci Transl Med. 2021;13:eabe0407.","journal-title":"Sci Transl Med"},{"key":"6043_CR16","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1136\/gutjnl-2019-319091","volume":"69","author":"A Dropmann","year":"2020","unstructured":"Dropmann A, Dooley S, Dewidar B, Hammad S, Dediulia T, Werle J, et al. TGF-beta2 silencing to target biliary-derived liver diseases. Gut. 2020;69:1677\u201390.","journal-title":"Gut."},{"key":"6043_CR17","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1074\/jbc.M407856200","volume":"280","author":"N Huang","year":"2005","unstructured":"Huang N, Negi S, Szebeni A, Olson MO. Protein NPM3 interacts with the multifunctional nucleolar protein B23\/nucleophosmin and inhibits ribosome biogenesis. J Biol Chem. 2005;280:5496\u2013502.","journal-title":"J Biol Chem"},{"key":"6043_CR18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S1097-2765(01)00354-9","volume":"8","author":"S Dutta","year":"2001","unstructured":"Dutta S, Akey IV, Dingwall C, Hartman KL, Laue T, Nolte RT, et al. The crystal structure of nucleoplasmin-core: implications for histone binding and nucleosome assembly. Mol Cell. 2001;8:841\u201353.","journal-title":"Mol Cell"},{"key":"6043_CR19","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1038\/sj.onc.1205708","volume":"21","author":"M Okuda","year":"2002","unstructured":"Okuda M. The role of nucleophosmin in centrosome duplication. Oncogene. 2002;21:6170\u20134.","journal-title":"Oncogene."},{"key":"6043_CR20","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/sj.onc.1201286","volume":"15","author":"T Kondo","year":"1997","unstructured":"Kondo T, Minamino N, NagamuraInoue T, Matsumoto M, Taniguchi T, Tanaka N. Identification and characterization of nucleophosmin\/B23\/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene. 1997;15:1275\u201381.","journal-title":"Oncogene."},{"key":"6043_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/1097-0215(20001101)88:3<392::AID-IJC11>3.0.CO;2-7","volume":"88","author":"CY Hsu","year":"2000","unstructured":"Hsu CY, Yung BYM. Over-expression of nucleophosmin\/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis. Int J Cancer. 2000;88:392\u2013400.","journal-title":"Int J Cancer"},{"key":"6043_CR22","doi-asserted-by":"publisher","first-page":"918","DOI":"10.4161\/cbt.4.9.2072","volume":"4","author":"KQ Ye","year":"2005","unstructured":"Ye KQ. Nucleophosmin\/B23, a multifunctional protein that can regulate apoptosis. Cancer Biol Ther. 2005;4:918\u201323.","journal-title":"Cancer Biol Ther"},{"key":"6043_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrc1885","volume":"6","author":"S Grisendi","year":"2006","unstructured":"Grisendi S, Mecucci C, Falini B, Pandolfi PP. Nucleophosmin and cancer. Nat Rev. Cancer. 2006;6:493.","journal-title":"Nat Rev. Cancer"},{"key":"6043_CR24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.urology.2004.05.020","volume":"64","author":"KH Tsui","year":"2004","unstructured":"Tsui KH, Cheng AJ, Chang P, Pan TL, Yung BY. Association of nucleophosmin\/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Urology. 2004;64:839\u201344.","journal-title":"Urology."},{"key":"6043_CR25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1158\/1535-7163.MCT-08-1056","volume":"8","author":"Y Perera","year":"2009","unstructured":"Perera Y, Farina HG, Gil J, Rodriguez A, Benavent F, Castellanos L, et al. Anticancer peptide CIGB-300 binds to nucleophosmin\/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity. Mol Cancer Ther. 2009;8:1189\u201396.","journal-title":"Mol Cancer Ther"},{"key":"6043_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nbt1396","volume":"26","author":"Y Sato","year":"2008","unstructured":"Sato Y, Murase K, Kato J, Kobune M, Sato T, Kawano Y, et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol. 2008;26:431\u201342.","journal-title":"Nat Biotechnol"},{"key":"6043_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.biocel.2015.07.007","volume":"66","author":"B Peng","year":"2015","unstructured":"Peng B, Liu F, Han R, Luo G, Cathopoulis T, Lu K, et al. Dynamic metabolic change is indicative of inflammation-induced transformation of hepatic cells. Int J Biochem Cell B. 2015;66:45\u201358.","journal-title":"Int J Biochem Cell B."},{"key":"6043_CR28","doi-asserted-by":"publisher","first-page":"44821","DOI":"10.18632\/oncotarget.8599","volume":"7","author":"A Di Matteo","year":"2016","unstructured":"Di Matteo A, Franceschini M, Chiarella S, Rocchio S, Travaglini-Allocatelli C, Federici L. Molecules that target nucleophosmin for cancer treatment: an update. Oncotarget. 2016;7:44821\u201340.","journal-title":"Oncotarget."},{"key":"6043_CR29","doi-asserted-by":"publisher","first-page":"16584","DOI":"10.1073\/pnas.0807668105","volume":"105","author":"SB Lee","year":"2008","unstructured":"Lee SB, Xuan Nguyen TL, Choi JW, Lee KH, Cho SW, Liu Z, et al. Nuclear Akt interacts with B23\/NPM and protects it from proteolytic cleavage, enhancing cell survival. Proc Natl Acad Sci USA. 2008;105:16584\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6043_CR30","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/antiox9121279","volume":"9","author":"E Ramos-Tovar","year":"2020","unstructured":"Ramos-Tovar E, Muriel P. Molecular mechanisms that link oxidative stress, inflammation, and fibrosis in the liver. Antioxidants. 2020;9:1279.","journal-title":"Antioxidants"},{"key":"6043_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0648-1","volume":"16","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Hu XB, Liu YJ, Dong SM, Wen ZW, He WM, et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer. 2017;16:79.","journal-title":"Mol Cancer"},{"key":"6043_CR32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cmet.2011.07.014","volume":"14","author":"JW Locasale","year":"2011","unstructured":"Locasale JW, Cantley LC. Metabolic flux and the regulation of mammalian cell growth. Cell Metab. 2011;14:443\u201351.","journal-title":"Cell Metab"},{"key":"6043_CR33","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12:931\u201347.","journal-title":"Nat Rev Drug Discov"},{"key":"6043_CR34","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1002\/jcb.26135","volume":"118","author":"GY Liu","year":"2017","unstructured":"Liu GY, Shi JX, Shi SL, Liu F, Rui G, Li X, et al. Nucleophosmin regulates intracellular oxidative stress homeostasis via antioxidant PRDX6. J Cell Biochem. 2017;118:4697\u2013707.","journal-title":"J Cell Biochem"},{"key":"6043_CR35","doi-asserted-by":"publisher","first-page":"106233","DOI":"10.1016\/j.biocel.2022.106233","volume":"147","author":"D Wang","year":"2022","unstructured":"Wang D, Li Y, Liu Y, Cheng S, Liu F, Zuo R, et al. NPM1 promotes cell proliferation by targeting PRDX6 in colorectal cancer. Int J Biochem Cell Biol. 2022;147:106233.","journal-title":"Int J Biochem Cell Biol"},{"key":"6043_CR36","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","volume":"9","author":"N Roehlen","year":"2020","unstructured":"Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020;9:875.","journal-title":"Cells"},{"key":"6043_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fphar.2019.00215","volume":"10","author":"R Bijkerk","year":"2019","unstructured":"Bijkerk R, Au YW, Stam W, Duijs JMGJ, Koudijs A, Lievers E, et al. Long non-coding RNAs Rian and Miat mediate myofibroblast formation in kidney fibrosis. Front Pharmacol. 2019;10:215.","journal-title":"Front Pharmacol"},{"key":"6043_CR38","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/hep.20965","volume":"42","author":"S Aleffi","year":"2005","unstructured":"Aleffi S, Petrai I, Bertolani C, Parola M, Colombatto S, Novo E, et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology. 2005;42:1339\u201348.","journal-title":"Hepatology."},{"key":"6043_CR39","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1053\/j.gastro.2003.11.018","volume":"126","author":"R Bataller","year":"2004","unstructured":"Bataller R, Paik YH, Lindquist JN, Lemasters JJ, Brenner DA. Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology. 2004;126:529\u201340.","journal-title":"Gastroenterology."},{"key":"6043_CR40","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1089\/ars.2013.5746","volume":"21","author":"VO Kaminskyy","year":"2014","unstructured":"Kaminskyy VO, Zhivotovsky B. Free radicals in cross talk between autophagy and apoptosis. Antioxid Redox Signal. 2014;21:86\u2013102.","journal-title":"Antioxid Redox Signal."},{"key":"6043_CR41","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/iub.2264","volume":"72","author":"I Yudushkin","year":"2020","unstructured":"Yudushkin I. Control of Akt activity and substrate phosphorylation in cells. IUBMB Life. 2020;72:1115\u201325.","journal-title":"IUBMB Life"},{"key":"6043_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5483\/BMBRep.2010.43.2.127","volume":"43","author":"IS Kwon","year":"2010","unstructured":"Kwon IS, Lee KH, Choi JW, Ahn JY. PI(3,4,5)P3 regulates the interaction between Akt and B23 in the nucleus. BMB Rep. 2010;43:127\u201332.","journal-title":"BMB Rep"},{"key":"6043_CR43","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1038\/onc.2008.54","volume":"27","author":"W Qi","year":"2008","unstructured":"Qi W, Shakalya K, Stejskal A, Goldman A, Beeck S, Cooke L, et al. NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells. Oncogene. 2008;27:4210\u201320.","journal-title":"Oncogene."},{"key":"6043_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80224-1","volume":"11","author":"M Sasinkova","year":"2021","unstructured":"Sasinkova M, Herman P, Holoubek A, Strachotova D, Otevrelova P, Grebenova D, et al. NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization. Sci Rep. 2021;11:1084.","journal-title":"Sci Rep"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06043-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06043-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06043-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T05:01:44Z","timestamp":1693371704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06043-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["6043"],"URL":"https:\/\/doi.org\/10.1038\/s41419-023-06043-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,30]]},"assertion":[{"value":"20 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"575"}}